🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Xerostomia

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases NCT07284797Phase 11 site📍 Melbourne Xencor, Inc. · Tests: XmAb657 A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease NCT07737743Phase 225 sites📍 Clearwater📍 Tampa📍 Chicago Novartis Pharmaceuticals · Tests: DDY391, Placebo Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study NCT05106608NA1 site📍 Granada Universidad de Granada · Tests: Energy density photobiomodulation (7.5), Energy density photobiomodulation (3), Sham placebo Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases NCT06842316n/a1 site📍 Orléans Centre Hospitalier Régional d'Orléans · Tests: 1 blood sample, 40 mL (collection during a blood test, part of the standard of care for this disease) The Pathogenesis and Natural History of Sjogren's Disease NCT01425892n/a1 site📍 Bethesda National Institute of Dental and Craniofacial Research (NID… Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease NCT06805448Phase 1, Phase 21 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: MSC, Saline Water (Control) Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease NCT07843381n/a1 site📍 Beijing Peking University People's Hospital · Tests: Telitacicept 160mg, Conventional treatment Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases NCT07301164EARLY Phase 11 site📍 Beijing Peking University Third Hospital · Tests: BCT301 Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders NCT07180537NA1 site📍 Iowa City Terry L. Wahls · Tests: Creating Health Online Course, Delayed access to Creating Health Online Course TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE NCT07153276Phase 41 site📍 São Paulo University of Sao Paulo General Hospital · Tests: Fractional CO2 laser (vaginal), Promestriene Vaginal B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome NCT04931160NA1 site📍 Brest University Hospital, Brest · Tests: Blood, fluid, sells and urine samples Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1 NCT06714253Phase 1, Phase 25 sites📍 Palo Alto📍 Iowa City📍 Baltimore RiboX Therapeutics Ltd. · Tests: RXRG001, Placebo A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE NCT07118241Phase 27 sites📍 Sydney📍 Sydney📍 Brisbane Lubris Bio Pty Ltd · Tests: Recombinant Human Proteoglycan 4, Vehicle Control A Study of ATG-201 in Adult Participants With Autoimmune Diseases NCT07732309Phase 122 sites📍 Bengbu📍 Hefei📍 Beijing Antengene Biologics Limited · Tests: ATG-201 A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases NCT07413341Phase 11 site📍 Shanghai Therorna · Tests: TI-0032-III injection Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease NCT07281456Phase 21 site📍 Bethesda National Institute of Dental and Craniofacial Research (NID… · Tests: Tofacitinib Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia NCT06392711Phase 11 site📍 Madison University of Wisconsin, Madison · Tests: Mesenchymal Stromal Cells (MSC) Dose Level 0, Mesenchymal Stromal Cells (MSC) Dose Level 1 Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients NCT06984848NA1 site📍 Kubang Kerian ZAINAB MAT YUDIN · Tests: Oral7® mouth spray contains Natural Enzymes (Lactoperoxidase, Glucose Oxidase, Lactoferrin, Lysozyme), Calcium, Xylitol… Dental and Periodontal Status of Patients With Sjögren's Syndrome. NCT04848870n/a1 site📍 Ivry-sur-Seine Assistance Publique - Hôpitaux de Paris · Tests: Salivary samples Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity NCT03003572n/a8 sites📍 Bourgoin📍 Clermont-Ferrand📍 Grenoble Centre Hospitalier Universitaire de Saint Etienne · Tests: Blood samples Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases NCT06548607EARLY Phase 11 site📍 Bengbu Nanjing Bioheng Biotech Co., Ltd. · Tests: CD19 or CD19-BCMA CAR-T Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases NCT06428188Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: BCMA/CD19 CAR-T cells d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC NCT04392622Phase 11 site📍 Stanford Stanford University · Tests: D-Limonene Gelcaps, Intensity modulated radiotherapy (IMRT), Cisplatin, Xerostomia questionnaire A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body NCT07649265Phase 11 site📍 Brisbane Otsuka Pharmaceutical Development & Commercialization, Inc. · Tests: HBM7020 An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease NCT06379646NA1 site📍 Shanghai China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome NCT04981145Phase 41 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases NCT05904301n/a6 sites📍 Yerevan📍 Yerevan📍 Yerevan Santé Arménie French-Armenian Research Center · Tests: Usual medical management of patients, additional blood and stool samples for biobanking Rheumatology Patient Registry and Biorepository NCT04402086n/a1 site📍 New Haven Yale University Xerostomia-optimised IMRT Versus Standard IMRT in NPC NCT06282497NA1 site📍 Zhongshan Zhongshan People's Hospital, Guangdong, China · Tests: Optimised neck CTV, standard neck CTV
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy